semaglutide baylor scott and white Beyond weight loss: Could GLP-1 agonists improve your heart health? Baylor Scott & White Clinic
Description
"For GPs and diabetic specialists out there, if you've got someone in your clinic who has obesity or type-2 diabetes as well as depression or anxiety, it's worth thinking about." The drugs contain the same active ingredient: semaglutide
Doses ranging from 0.25 mg to 1.0 mg daily have been investigated

Too much of the drug in your body can be dangerous

The supply of unlicensed medicines in the UK is unlawful, and individuals purchasing such products may unknowingly receive counterfeit, contaminated, or mislabelled substances
The risk of cardiovascular complications with current obesity drugs